Product Code: ETC070018 | Publication Date: Jul 2023 | Updated Date: Aug 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
Contract cell and gene therapy manufacturing involves outsourcing the production of cell and gene therapies to specialized manufacturing facilities. These therapies hold immense potential for treating a wide range of genetic and chronic diseases, and their development requires specialized infrastructure and expertise.
The ongoing advancements in cell and gene therapies have increased the demand for contract manufacturing services to scale up production and meet clinical trial requirements.The Saudi Arabia government`s initiatives to promote biotechnology and advanced medical therapies may drive investment in the contract cell and gene therapy manufacturing sector.The prevalence of genetic and chronic diseases in Saudi Arabia creates a demand for novel therapies like cell and gene therapies.
The contract manufacturing organizations (CMOs) need to adhere to stringent regulatory standards and quality control measures to ensure the safety and efficacy of cell and gene therapies. Manufacturing cell and gene therapies require highly specialized expertise, equipment, and facilities, which might pose challenges for some CMOs.
The Covid-19 pandemic may have had varying impacts on the Contract Cell and Gene Therapy Manufacturing market in Saudi Arabia. While the pandemic may have caused disruptions in the supply chain and clinical trials, the focus on advanced medical therapies and the need for innovative treatment options may have continued to drive interest in cell and gene therapies.
Lonza Group Ltd., Catalent, Inc., Thermo Fisher Scientific Inc., FUJIFILM Diosynth Biotechnologies, WuXi AppTec Co., Ltd., and Samsung Biologics are some significantplayers operating in the market tremendously.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Saudi Arabia Contract Cell and Gene Therapy Manufacturing Market Overview |
3.1 Saudi Arabia Country Macro Economic Indicators |
3.2 Saudi Arabia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, 2021 & 2031F |
3.3 Saudi Arabia Contract Cell and Gene Therapy Manufacturing Market - Industry Life Cycle |
3.4 Saudi Arabia Contract Cell and Gene Therapy Manufacturing Market - Porter's Five Forces |
3.5 Saudi Arabia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume Share, By Vector, 2021 & 2031F |
3.6 Saudi Arabia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Saudi Arabia Contract Cell and Gene Therapy Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government support and investments in healthcare infrastructure and innovation |
4.2.2 Rising prevalence of chronic diseases driving demand for advanced cell and gene therapies |
4.2.3 Growing collaborations between research institutions, biotech companies, and contract manufacturing organizations in Saudi Arabia |
4.3 Market Restraints |
4.3.1 Lack of skilled workforce and expertise in cell and gene therapy manufacturing |
4.3.2 Regulatory challenges and uncertainties surrounding cell and gene therapy production in the region |
4.3.3 Limited access to advanced technologies and infrastructure for manufacturing processes |
5 Saudi Arabia Contract Cell and Gene Therapy Manufacturing Market Trends |
6 Saudi Arabia Contract Cell and Gene Therapy Manufacturing Market, By Types |
6.1 Saudi Arabia Contract Cell and Gene Therapy Manufacturing Market, By Vector |
6.1.1 Overview and Analysis |
6.1.2 Saudi Arabia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Vector, 2021-2031F |
6.1.3 Saudi Arabia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Viral Vector, 2021-2031F |
6.1.4 Saudi Arabia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Non-viral Vector, 2021-2031F |
6.2 Saudi Arabia Contract Cell and Gene Therapy Manufacturing Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Saudi Arabia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Cancer, 2021-2031F |
6.2.3 Saudi Arabia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Neurological Diseases, 2021-2031F |
6.2.4 Saudi Arabia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Hepatological Diseases, 2021-2031F |
6.2.5 Saudi Arabia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Others, 2021-2031F |
7 Saudi Arabia Contract Cell and Gene Therapy Manufacturing Market Import-Export Trade Statistics |
7.1 Saudi Arabia Contract Cell and Gene Therapy Manufacturing Market Export to Major Countries |
7.2 Saudi Arabia Contract Cell and Gene Therapy Manufacturing Market Imports from Major Countries |
8 Saudi Arabia Contract Cell and Gene Therapy Manufacturing Market Key Performance Indicators |
8.1 Percentage increase in research and development funding for cell and gene therapy manufacturing |
8.2 Number of clinical trials in cell and gene therapy conducted in Saudi Arabia |
8.3 Rate of adoption of international quality standards and certifications in cell and gene therapy manufacturing operations |
9 Saudi Arabia Contract Cell and Gene Therapy Manufacturing Market - Opportunity Assessment |
9.1 Saudi Arabia Contract Cell and Gene Therapy Manufacturing Market Opportunity Assessment, By Vector, 2021 & 2031F |
9.2 Saudi Arabia Contract Cell and Gene Therapy Manufacturing Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Saudi Arabia Contract Cell and Gene Therapy Manufacturing Market - Competitive Landscape |
10.1 Saudi Arabia Contract Cell and Gene Therapy Manufacturing Market Revenue Share, By Companies, 2024 |
10.2 Saudi Arabia Contract Cell and Gene Therapy Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |